Literature DB >> 9460732

Visual and spatial perception in the early phase of Alzheimer's disease.

G Binetti1, S F Cappa, E Magni, A Padovani, A Bianchetti, M Trabucchi.   

Abstract

A battery of visuospatial perception tests was administered to 27 mild probable Alzheimer's disease (AD) patients; 21 were reassessed after 8 months. At the first evaluation, AD patients were impaired only in an object-naming task. After 8 months, the performance in the subtests of object perception was unchanged, while there was a significant decline in the total score of the items tapping space perception. A significant worsening was also observed in the Rey's figure copy score and was correlated with the decrease in the spatial perception score. This study confirms that an impairment in visual perceptual tests requiring access to semantic and lexical knowledge is present in the earliest phase of AD, whereas visuospatial and constructional impairments became evident only later. This pattern of progression may represent the clinical correlate of increasing pathological involvement of posterior associative cortex.

Entities:  

Mesh:

Year:  1998        PMID: 9460732     DOI: 10.1037//0894-4105.12.1.29

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  16 in total

1.  Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

Authors:  K R Thulborn; C Martin; J T Voyvodic
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

2.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 3.  A biased competition account of attention and memory in Alzheimer's disease.

Authors:  Kathrin Finke; Nicholas Myers; Peter Bublak; Christian Sorg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-09       Impact factor: 6.237

4.  Non-verbal memory measured by Rey-Osterrieth Complex Figure B: normative data.

Authors:  Simona Luzzi; Martina Pesallaccia; Katia Fabi; Marco Muti; Giovanna Viticchi; Leandro Provinciali; Massimo Piccirilli
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

5.  Biparietal variant of Alzheimer's disease: a rare presentation of a common disease.

Authors:  Inês B Marques; Miguel Tábuas-Pereira; Miguel Milheiro; Isabel Santana
Journal:  BMJ Case Rep       Date:  2015-01-05

6.  Category-specific semantic memory: converging evidence from bold fMRI and Alzheimer's disease.

Authors:  Murray Grossman; Jonathan E Peelle; Edward E Smith; Corey T McMillan; Philip Cook; John Powers; Michael Dreyfuss; Michael F Bonner; Lauren Richmond; Ashley Boller; Emily Camp; Lisa Burkholder
Journal:  Neuroimage       Date:  2012-12-06       Impact factor: 6.556

Review 7.  Sex differences in cognitive impairment in Alzheimer's disease.

Authors:  Keith R Laws; Karen Irvine; Tim M Gale
Journal:  World J Psychiatry       Date:  2016-03-22

8.  Object perception impairments predict instrumental activities of daily living dependence in Alzheimer's disease.

Authors:  Angela L Jefferson; Lamia P Barakat; Tania Giovannetti; Robert H Paul; Guila Glosser
Journal:  J Clin Exp Neuropsychol       Date:  2006-08       Impact factor: 2.475

9.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

10.  Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery.

Authors:  Natália Bezerra Mota Quental; Sonia Maria Dozzi Brucki; Orlando Francisco Amodeo Bueno
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.